Skip to content

FLEURUS MEDICAL

Judicial reorganisation Private limited companyfounded 1990active for 36 yearsAvenue du Marquis, 6220 FleurusKBO/BCE: BE 0440.592.608

Board

2 directors, no change since 2019
Manager (not named in the articles)
appointed by deed of 08-11-2007 term without a fixed end
listed in the 2025 annual accounts, filed on 20-10-2026
Manager
appointed by deed of 04-06-2019 term without a fixed end
listed in the 2025 annual accounts, filed on 20-10-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each manager alone
deed of 08-11-2007

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Manager (not named in the articles)

Manager
Board
Mandates as a list
    • Manager (not named in the articles), appointed by deed of 08-11-2007, still in office
    • Manager, appointed by deed of 04-06-2019, still in office
With Starter you also see 1 former office holder in the mandate history. See the plans →

See the board, name and registered office on a given date →

Control

Shareholder
1,775 voting rights
50%
This company
FLEURUS MEDICAL
Equity -€253,976
Loss €427,073 in 2025

and 2 other shareholders

Capital

Contribution
€600,000
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
50%
25%
25%
Owners as a list

Source: shareholder structure in its own accounts

Articles of association

deed of 30-12-2024 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Moitié cédant moitié acquéreurs proportionnellement nombre actions, écrit par pli recommandé
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Tuesday of March at 18:00

Shareholders

3 owners

Owners 3

  • individual shareholder
    50%1,775 voting rights
  • individual shareholder
    25%887 voting rights
  • individual shareholder
    25%888 voting rights

Capital transactions

Shareholders according to the deeds
After the capital increase deed of 30-12-2024 ↗
  • €291,997.80 in kind
  • €100,000 in kind
  • €120,000 in kind
Capital over time
  1. 30-12-2024 Capital increase of €511,997.80 · to €600 · 20,654 new shares at €24.79 per share · in kind
  2. 30-12-2024 Converted to unavailable equity